Elevance Health, Inc.

ELV

US0367521038

Managed Healthcare

Market Closed - Nyse Other stock markets 04:00:01 2024-04-25 pm EDT			5-day change	1st Jan Change
539.7 ^USD	+1.11%		+2.76%	+14.45%

01:45pm	HCA beats first-quarter profit estimates on higher patient admissions	RE
Apr. 25	Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing	MT

Anthem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

April 24, 2019 at 06:00 am EDT

Anthem, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 24,666 million compared to USD 22,537 million a year ago. Net income was USD 1,551 million compared to USD 1,312 million a year ago. Diluted earnings per share was USD 5.91 compared to USD 4.99 a year ago.

Latest news about Elevance Health, Inc.

HCA beats first-quarter profit estimates on higher patient admissions	07:45am	RE
Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing	Apr. 25	MT
Molina Healthcare beats profit estimates aided by higher premiums	Apr. 24	RE
Mizuho Adjusts Price Target on Elevance Health to $585 From $575	Apr. 24	MT
TD Cowen Adjusts Elevance Health's Price Target to $624 From $555	Apr. 23	MT
UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating	Apr. 19	MT
Bernstein Adjusts Price Target on Elevance Health to $665 From $629	Apr. 19	MT
Leerink Partners Adjusts Elevance Health Price Target to $630 From $565	Apr. 19	MT
Jefferies & Co Adjusts Elevance Health Price Target to $604 From $602	Apr. 19	MT
Goldman Sachs Raises Elevance Health's Price Target to $600 From $578	Apr. 19	MT
RBC Lifts Price Target on Elevance Health to $575 From $574, Cites 'Stronger Guidance,' Keeps Outperform Rating	Apr. 19	MT
Truist Lifts Price Target on Elevance Health to $600 From $580, Notes 'Solid' Q1, 2024 Guidance Boost, Keeps Buy Rating	Apr. 19	MT
Wells Fargo Adjusts Elevance Health's Price Target to $600 From $557, Maintains Overweight Rating	Apr. 19	MT
Barclays Adjusts Elevance Health's Price Target to $621 From $584, Maintains Overweight Rating	Apr. 19	MT
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	Apr. 18	MT
Tranche Update on Elevance Health, Inc.'s Equity Buyback Plan announced on October 26, 2004.	Apr. 18	CI
Sector Update: Health Care Stocks Ease in Afternoon Trading	Apr. 18	MT
Elevance Health Shares Rise After Q1 Results Top Estimates, Analysts Boost Price Targets	Apr. 18	MT
Cantor Fitzgerald Raises Elevance Health Price Target to $600 from $580	Apr. 18	MT
Stephens Adjusts Elevance Health's Price Target to $615 From $580	Apr. 18	MT
Wall St ticks up on megacaps, earnings boost	Apr. 18	RE
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
Top Midday Stories: Taiwan Semiconductor Manufacturing, Blackstone, Elevance Health, D.R. Horton, Infosys and Marsh & McLennan Report Earnings; Tesla's Musk Says Laid-Off Employees Received "Incorrectly Low" Severance; 23andME CEO Mulls Taking Company Private; Northrop Grumman Working with SpaceX on Spy Satellite	Apr. 18	MT
Elevance Health Raises 2024 Earnings Outlook After Mixed First Quarter	Apr. 18	MT
Tech strength lifts Wall Street	Apr. 18

Chart Elevance Health, Inc.

Duration

Period

More charts

Company Profile

Elevance Health, Inc. is the American leading of health insurance. The group provides a broad range of medical and specialty products and services (life and disability insurance, medication, dental, vision insurance system and behavioral care insurance system, long-term health care insurance, medical expenses management, etc.). Elevance Health, Inc. is an independent licensee of the Blue Cross and Blue Shield Association, an independent association providing health insurance system. At the end of 2023, the group had nearly 47 million medical members.

Sector

Managed Healthcare

Calendar

2024-05-15 - Annual General Meeting

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Elevance Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

539.7 USD

Average target price

599.5 USD

Spread / Average Target

+11.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

	1st Jan change	Capi.
ELEVANCE HEALTH, INC.	+14.45%	125B
UNITEDHEALTH GROUP INC.	-6.19%	454B
CIGNA	+18.39%	101B
CENTENE CORPORATION	+1.98%	40.48B
HUMANA INC.	-31.98%	37.53B
MOLINA HEALTHCARE, INC.	-2.49%	20.64B
ALIGNMENT HEALTHCARE, INC.	-40.07%	975M
CLOVER HEALTH INVESTMENTS, CORP.	-29.63%	332M

Other Managed Healthcare

Elevance Health, Inc.

Equities

ELV

US0367521038

Managed Healthcare

Anthem, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019

EPS Revisions